Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Eating dairy and high glycemic foods may increase the risk of acne.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Early diagnosis and treatment of TPP can prevent complications.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.